Intrahepatic Transcriptomics Differentiate Advanced Fibrosis and Clinical Outcomes in Adults With Fontan Circulation

Katia Bravo-Jaimes1, Xiuju Wu2, Leigh C Reardon3

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA; Ahmanson/UCLA Adult Congenital Heart Disease Center, University of California, Los Angeles, California, USA.

Summary

Fontan-associated liver disease (FALD) shows distinct molecular signatures in advanced fibrosis and adverse outcomes. Key upregulated genes indicate inflammation, congestion, and angiogenesis, offering insights into FALD progression.